Last reviewed · How we verify

Fluoxacillin — Competitive Intelligence Brief

Fluoxacillin (FLOXACILLIN) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: floxacillin. Area: Other.

marketed floxacillin Matrix metalloproteinase-9, Androgen receptor, Penicillin-binding protein 1A Other Small molecule Live · refreshed every 30 min

Target snapshot

Fluoxacillin (FLOXACILLIN).

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fluoxacillin TARGET FLOXACILLIN marketed floxacillin Matrix metalloproteinase-9, Androgen receptor, Penicillin-binding protein 1A
flucloxacillin flucloxacillin Karlstad University marketed Matrix metalloproteinase-9, Androgen receptor, Penicillin-binding protein 1A

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (floxacillin class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fluoxacillin — Competitive Intelligence Brief. https://druglandscape.com/ci/floxacillin. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing